Product Overview
Generic name: Yimaikang tablets
Chinese Pinyin: YiMaiKangPian
Product name: Merri
Ingredients: Dengzhanxixin extract. The main chemical components are flavonoids (main components), lactones, amino acids, polysaccharides, etc., such as Pgromeconic acid and its glucoside, breviscapine B (Scutellarin), apigenin (Apigenin), luteolin Su (Luleolin).
Properties: This product is a film-coated tablet, which is brown after removing the film coating; the taste is slightly bitter.
Functions and indications: Promoting blood circulation to remove blood stasis, improving cerebral blood circulation, increasing cerebral blood flow, increasing myocardial tolerance to ischemia and hypoxia, and improving microcirculation. It is used for ischemic cerebrovascular disease and paralysis after cerebral hemorrhage, retinal vein occlusion of the fundus, coronary heart disease, vasculitis skin disease, rheumatism; advanced glaucoma visual field reduction with controlled intraocular pressure after trabeculectomy.
Specification: 40mg*30 tablets/box
Usage and dosage: Oral. 2 tablets at a time, three times a day.
Adverse reactions: not yet clear
Taboo: Not clear yet
Note: Not yet clear
Pharmacology and Toxicology: The results of pre-clinical animal experiments suggest that Merrill can reduce the content of malondialdehyde (MDA) in rabbits with chronic ocular hypertension, increase the activity of superoxide dismutase (SOD); reduce the permeability of retinal blood vessels ; Increase the gray scale and the density of active ganglion cells in the retina caused by acute ocular hypertension in rats.
Storage: sealed and protected from light.
Packaging: PVC rigid film, aluminum-plastic blister packaging. 30 pieces / board * 1 board / box.
Validity period: 36 months
Approval number: National Medicine Standard Z20010081
Company Name: Hunan Xiangya Pharmaceutical Co., Ltd.
Company Address: Tongzipo, Yuelu District, Changsha City, Hunan Province
